Back to Agenda
Session 1 - GVP Module XVI - the 3rd Revision
Speaker(s)
The revised GVP Module XVI - What to focus on for implementing the guidance
Priya Bahri, PhD, RPh
European Medicines Agency, Netherlands
Senior Lead (Pharmacovigilance and Risk Management Guidance and Policy)
Conceptional approach to RMM effectiveness evaluation
Thomas Goedecke, PharmD, PhD
European Medicines Agency, Netherlands
Senior Pharmacovigilance Specialist
Roberto Frontini
Centre for Patient Safety Leipzig, Germany
Director of Pharmacy
Have an account?